Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1

Conditions

Neuroblastoma 1Neoplasms 1Ganglioneuroblastoma 1

Interventions

pembrolizumab 67Cyclophosphamide 45Cisplatin 45Nivolumab 39Paclitaxel 35Carboplatin 31Radiotherapy 30Gemcitabine 28Docetaxel 27Dexamethasone 23atezolizumab 22Bevacizumab 20Doxorubicin 19Vincristine 17Magnetic Resonance Spectroscopy 17Lenalidomide 17fludarabine 16Radiosurgery 16Fluorouracil 16Etoposide 16Blood Specimen Collection 16Rituximab 15Radiation 15Letrozole 15Irinotecan 15Ipilimumab 15palbociclib 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Isotretinoin × 90 days × Clear all
NCT03786783 2026-06-02

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Completed
42 enrolled 12 charts
CNS

Ganglioneuroblastoma

NCT03611595 2026-05-27

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

University of California, San Diego

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasms

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡